P11.05.B BENEFITS OF SODIUM FLUORESCEIN IN RESECTION OF BRAIN METASTASES

Abstract BACKGROUND For central nervous system (CNS) tumors, the use of intraoperative fluorophores can significantly improve resection in several ways. Although sodium fluorescein (Na-Fl) has been used for CNS tumors since the 1940s, experience and use of Na-Fl is relatively limited. To date, existing studies of Na-Fl assisted resection of brain metastases (BM) have involved a limited number of patients. MATERIAL AND METHODS Any patient at our institution who underwent resection of a cerebral lesion suspected of being BM between November 2023 and March 2025 received 200 mg 10% Na-Fl solution during induction of anaesthesia. The multidisciplinary tumor board confirmed the indication for any BM resection. A 560 nm filter microscope was used for intraoperative fluorescence guidance. Fluorescence patterns and extent of resection according to early postoperative cT1w MRI were recorded. Postoperative overall survival was determined for the available cases. RESULTS We enrolled 67 patients (28 females, mean age of 64 ±10 years) who underwent resection of at least 1 BM using intraoperative Na-Fl induced fluorescence. 43 patients had singular and 25 patients had multiple BM. Na-Fl fluorescence was positive in 94%, negative in 3% and not documented in another 3% of cases. Most common primary cancers were non-small cell lung cancer (43.3%), gastrointestinal carcinoma (13.4%), and malignant melanoma (10.4%). No negative side effects of Na-Fl were observed in any patient. Cost per patient was 12€. According to postoperative MRI, a gross total resection could be achieved in 64.2% of cases. Long-term data were available for 32 patients. Median follow-up time was 3.9 months (SD 3.8), and 6-month survival rate was 46.9%. Overall survival was statistically significantly different between patients with singular or multiple metastases (p<0.006, Log rank test). CONCLUSION Na-Fl facilitates intraoperative detection of BM. It appears to be safe, inexpensive and easy to use. However, Na-Fl also appears to accumulate in the adjacent areas of impaired blood-brain barrier. Further studies are warranted to investigate the benefits of using Na-Fl to improve the extent of resection.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2025-10-01
DOI
https://doi.org/10.1093/neuonc/noaf193.344
Primary Topic
Radiopharmaceutical Chemistry and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P11.05.B BENEFITS OF SODIUM FLUORESCEIN IN RESECTION OF BRAIN METASTASES

Dagmar Taeuscher, A. Neumeister, Thomas Ernst, T. Meier et al.
Neuro-Oncology
Radiopharmaceutical Chemistry and Applications
article

P11.05.B BENEFITS OF SODIUM FLUORESCEIN IN RESECTION OF BRAIN METASTASES

Dagmar Taeuscher, A. Neumeister, Thomas Ernst, T. Meier, Christian Senft, Klaus Pietschmann, Paul De Bank, Lydia Karamani, Nico Andreas, Sophie Kubon
article en

Abstract

Abstract BACKGROUND For central nervous system (CNS) tumors, the use of intraoperative fluorophores can significantly improve resection in several ways. Although sodium fluorescein (Na-Fl) has been used for CNS tumors since the 1940s, experience and use of Na-Fl is relatively limited. To date, existing studies of Na-Fl assisted resection of brain metastases (BM) have involved a limited number of patients. MATERIAL AND METHODS Any patient at our institution who underwent resection of a cerebral lesion suspected of being BM between November 2023 and March 2025 received 200 mg 10% Na-Fl solution during induction of anaesthesia. The multidisciplinary tumor board confirmed the indication for any BM resection. A 560 nm filter microscope was used for intraoperative fluorescence guidance. Fluorescence patterns and extent of resection according to early postoperative cT1w MRI were recorded. Postoperative overall survival was determined for the available cases. RESULTS We enrolled 67 patients (28 females, mean age of 64 ±10 years) who underwent resection of at least 1 BM using intraoperative Na-Fl induced fluorescence. 43 patients had singular and 25 patients had multiple BM. Na-Fl fluorescence was positive in 94%, negative in 3% and not documented in another 3% of cases. Most common primary cancers were non-small cell lung cancer (43.3%), gastrointestinal carcinoma (13.4%), and malignant melanoma (10.4%). No negative side effects of Na-Fl were observed in any patient. Cost per patient was 12€. According to postoperative MRI, a gross total resection could be achieved in 64.2% of cases. Long-term data were available for 32 patients. Median follow-up time was 3.9 months (SD 3.8), and 6-month survival rate was 46.9%. Overall survival was statistically significantly different between patients with singular or multiple metastases (p<0.006, Log rank test). CONCLUSION Na-Fl facilitates intraoperative detection of BM. It appears to be safe, inexpensive and easy to use. However, Na-Fl also appears to accumulate in the adjacent areas of impaired blood-brain barrier. Further studies are warranted to investigate the benefits of using Na-Fl to improve the extent of resection.

Neuro-OncologyVol. 27(Supplement_3)
SRH Wald-Klinikum Gera (DE), Jena University Hospital (DE)
Openalex Percentile: Top 59%
Radiopharmaceutical Chemistry and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.